Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefanescu

Showing results (611-620 of 663) with videos related to

Pageof 67
Sort By:
Alimentary Pharmacology & Therapeutics|December 19, 2022
Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort studyMathurin Fumery, Antoine Defrance, Xavier Roblin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 8, 2017
Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel DiseasesDiane Lorenzo, Frédérique Maire, Carmen Stefanescu, et al.
Respiratory Medicine|July 26, 2021
Qualitative coronary artery calcification scores and risk of all cause, COPD and pneumonia hospital admission in a large CT lung cancer screening cohortLee Gazourian, Shawn M Regis, Elizabeth J Pagura, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2023
Adalimumab in Biologic-naïve Patients With Crohn's Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAIDYoram Bouhnik, Guillaume Pineton de Chambrun, Jérôme Lambert, et al.
Journal of Crohn'S & Colitis|July 13, 2016
Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID CohortYael Abitbol, David Laharie, Jacques Cosnes, et al.
Cell Reports|August 4, 2022
Cancer genes disfavoring T cell immunity identified via integrated systems approachRigel J Kishton, Shashank J Patel, Amy E Decker, et al.
Journal of Crohn'S & Colitis|September 10, 2025
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAIDPauline Wils, Romain Altwegg, Anthony Buisson, et al.
Inflammatory Bowel Diseases|October 12, 2021
Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAIDCatherine Reenaers, Arnaud de Roover, Laurent Kohnen, et al.
Lung|September 5, 2020
Quantitative Pectoralis Muscle Area is Associated with the Development of Lung Cancer in a Large Lung Cancer Screening CohortLee Gazourian, Chantal S Durgana, Devon Huntley, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 27, 2016
Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel DiseaseAurelien Amiot, Jean-Charles Grimaud, Laurent Peyrin-Biroulet, et al.
Pageof 67

Showing results (611-620 of 663) with videos related to

Sort By:
Pageof 67
Alimentary Pharmacology & Therapeutics|December 19, 2022
Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort studyMathurin Fumery, Antoine Defrance, Xavier Roblin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 8, 2017
Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel DiseasesDiane Lorenzo, Frédérique Maire, Carmen Stefanescu, et al.
Respiratory Medicine|July 26, 2021
Qualitative coronary artery calcification scores and risk of all cause, COPD and pneumonia hospital admission in a large CT lung cancer screening cohortLee Gazourian, Shawn M Regis, Elizabeth J Pagura, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2023
Adalimumab in Biologic-naïve Patients With Crohn's Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAIDYoram Bouhnik, Guillaume Pineton de Chambrun, Jérôme Lambert, et al.
Journal of Crohn'S & Colitis|July 13, 2016
Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID CohortYael Abitbol, David Laharie, Jacques Cosnes, et al.
Cell Reports|August 4, 2022
Cancer genes disfavoring T cell immunity identified via integrated systems approachRigel J Kishton, Shashank J Patel, Amy E Decker, et al.
Journal of Crohn'S & Colitis|September 10, 2025
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAIDPauline Wils, Romain Altwegg, Anthony Buisson, et al.
Inflammatory Bowel Diseases|October 12, 2021
Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAIDCatherine Reenaers, Arnaud de Roover, Laurent Kohnen, et al.
Lung|September 5, 2020
Quantitative Pectoralis Muscle Area is Associated with the Development of Lung Cancer in a Large Lung Cancer Screening CohortLee Gazourian, Chantal S Durgana, Devon Huntley, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 27, 2016
Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel DiseaseAurelien Amiot, Jean-Charles Grimaud, Laurent Peyrin-Biroulet, et al.
Pageof 67